Instylla
MA - BedfordBiotechnology
Focus: Instylla is a Massachusetts-based biotechnology company specializing in embolization treatments for oncology, with a focused pipeline of device-drug combination products.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
3-2 this month
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Should You Work at Instylla?
AI assessmentInstylla represents a high-risk, high-reward opportunity for professionals seeking ground-floor involvement in a specialized oncology-focused device-drug company, but career stability depends on undisclosed funding and regulatory progress.
Why Work Here
- Early-stage company with specialized focus on high-unmet-need embolization therapies in oncology and vascular intervention
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Instylla HES
Hypervascular TumorsClinical Trials (1)
NCT04523350Instylla HES Hypervascular Tumor Pivotal Study
N/AHelp build intelligence for Instylla
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.